Vivo Ventures VI, LLC

10% owner at AVANIR PHARMACEUTICALS, INC. · on record since Aug 13, 2009
10% owner at Sagent Pharmaceuticals, Inc. · on record since Apr 19, 2011
10% owner at KalVista Pharmaceuticals, Inc. · on record since Apr 24, 2015
10% owner at CELADON GROUP INC · on record since Mar 28, 2016

Insider trading activity of Vivo Ventures VI, LLC

Transactions on record: 20; since Aug 13, 2009

Open-market buys: 2; $5.1M

Open-market sells: 6; $14.2M

Companies traded: 3; last filing Apr 25, 2016

Figures computed from official regulatory filings — .

Companies where Vivo Ventures VI, LLC has traded

Sagent Pharmaceuticals, Inc.4 tx · $13.3M · Apr 25, 2016
KalVista Pharmaceuticals, Inc.14 tx · $5.1M · Apr 24, 2015
AVANIR PHARMACEUTICALS, INC.2 tx · $985K · Aug 13, 2009

Track record of Vivo Ventures VI, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Vivo Ventures VI, LLC

Co-insiders of Vivo Ventures VI, LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sagent Pharmaceuticals, Inc.Listing unverified	Apr 25, 2016	Sell	-2,299	13.55 USD	$31.2K		SEC
Sagent Pharmaceuticals, Inc.Listing unverified	Apr 25, 2016	Sell	-17	13.55 USD	$230.4		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-2,230	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	304,438	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	2,476,452	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-2,476,452	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-18,140	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	387,960	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	2,842	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Buy	7,364	5.00 USD	$36.8K	conv 49ClusterFirst in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-304,438	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-2,842	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	18,140	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Buy	1,005,136	5.00 USD	$5M	conv 62ClusterFirst in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-387,960	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	2,230	—	n/a (No price was disclosed in the filing)		SEC
Sagent Pharmaceuticals, Inc.Listing unverified	Sep 17, 2013	Sell	-4,529	21.25 USD	$96.2K		SEC
Sagent Pharmaceuticals, Inc.Listing unverified	Sep 17, 2013	Sell	-618,171	21.25 USD	$13.1M		SEC
AVANIR PHARMACEUTICALS, INC.Listing unverified	Aug 13, 2009	Sell	-49,800	4.05	$201.7K		SEC
AVANIR PHARMACEUTICALS, INC.Listing unverified	Aug 13, 2009	Sell	-232,450	3.37	$783.4K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sagent Pharmaceuticals, Inc.Listing unverified	Apr 25, 2016	Sell	-2,299	13.55 USD	$31.2K		SEC
Sagent Pharmaceuticals, Inc.Listing unverified	Apr 25, 2016	Sell	-17	13.55 USD	$230.4		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-2,230	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	304,438	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	2,476,452	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-2,476,452	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-18,140	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	387,960	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	2,842	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Buy	7,364	5.00 USD	$36.8K	conv 49ClusterFirst in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-304,438	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-2,842	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	18,140	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Buy	1,005,136	5.00 USD	$5M	conv 62ClusterFirst in 12mo	SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	OtherD (derivative)	-387,960	—	n/a (No price was disclosed in the filing)		SEC
KalVista Pharmaceuticals, Inc.Listing unverified	Apr 24, 2015	Other	2,230	—	n/a (No price was disclosed in the filing)		SEC
Sagent Pharmaceuticals, Inc.Listing unverified	Sep 17, 2013	Sell	-4,529	21.25 USD	$96.2K		SEC
Sagent Pharmaceuticals, Inc.Listing unverified	Sep 17, 2013	Sell	-618,171	21.25 USD	$13.1M		SEC
AVANIR PHARMACEUTICALS, INC.Listing unverified	Aug 13, 2009	Sell	-49,800	4.05	$201.7K		SEC
AVANIR PHARMACEUTICALS, INC.Listing unverified	Aug 13, 2009	Sell	-232,450	3.37	$783.4K		SEC